Corient Private Wealth’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.54M | Buy |
3,693,683
+302,200
| +9% | +$372K | ﹤0.01% | 787 |
|
2025
Q1 | $3.73M | Hold |
3,391,483
| – | – | 0.01% | 761 |
|
2024
Q4 | $3.07M | Hold |
3,391,483
| – | – | 0.01% | 847 |
|
2024
Q3 | $3.35M | Hold |
3,391,483
| – | – | 0.01% | 864 |
|
2024
Q2 | $3.06M | Buy |
3,391,483
+119,213
| +4% | +$107K | 0.01% | 858 |
|
2024
Q1 | $3.86M | Buy |
3,272,270
+334,339
| +11% | +$395K | 0.01% | 781 |
|
2023
Q4 | $2.68M | Buy |
2,937,931
+965,092
| +49% | +$881K | ﹤0.01% | 882 |
|
2023
Q3 | $1.64M | Buy |
1,972,839
+602,653
| +44% | +$502K | ﹤0.01% | 984 |
|
2023
Q2 | $1.64M | Buy |
1,370,186
+9,800
| +0.7% | +$11.8K | ﹤0.01% | 961 |
|
2023
Q1 | $1.71M | Buy |
1,360,386
+1,191,666
| +706% | +$1.5M | ﹤0.01% | 893 |
|
2022
Q4 | $366K | Buy |
+168,720
| New | +$366K | ﹤0.01% | 1254 |
|